Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
暂无分享，去创建一个
David A. Jolliffe | M. Talaei | F. Kee | S. Faustini | G. Davies | A. Martineau | A. Richter | S. Shaheen | R. Lyons | G. Vivaldi | M. Greenig | H. Holt | J. Symons | F. Tydeman | N. Perdek | S. Maltby | C. Griffiths | Aziz Sheikh